{"id":"W2550512372","doi":"10.4155/bio-2016-4988","title":"2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies)","year":2016,"lang":"en","type":"article","venue":"Bioanalysis","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Canada; Caprion (Canada)","funders":"Agenzia Italiana del Farmaco, Ministero della Salute; Health Canada; World Health Organization; Bristol-Myers Squibb; U.S. Food and Drug Administration; Sanofi; Angelini Pharma","keywords":"Bioanalysis; Biopharmaceutical; Immunogenicity; Excellence; White paper; Biosimilar; Computer science; Nanotechnology; Medicine; Political science; Biotechnology; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02402626,0.00154349,0.0009849365,0.001221481,0.002977452,0.01198242,0.003198873,0.01145392,0.02207934],"category_scores_gemma":[0.0210811,0.000790523,0.001340717,0.001651844,0.003390944,0.006799828,0.00396138,0.008848609,0.01910299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00475231,"about_ca_system_score_gemma":0.01231906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004257149,"about_ca_topic_score_gemma":0.007542934,"domain_scores_codex":[0.9883394,0.001873682,0.0009941687,0.001760144,0.006153598,0.0008790019],"domain_scores_gemma":[0.9721042,0.006190435,0.003179063,0.001822653,0.0122839,0.004419778],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001158745,0.0001539235,0.0003788057,0.0005352093,0.00001723392,0.0003330917,0.0005227934,0.0003169909,0.00604368,0.008593673,0.8934954,0.08949336],"study_design_scores_gemma":[0.000006971458,0.00004275181,0.0003088652,0.0001909462,0.000005118232,0.000101254,0.0001793135,0.0001079144,0.002510115,0.001633867,0.9948973,0.00001564013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.006088938,0.04356311,0.02000687,0.5035195,0.3157309,0.0007348378,0.001246022,0.0009397813,0.10817],"genre_scores_gemma":[0.03255179,0.04163057,0.02328467,0.1639502,0.09825042,0.0005891425,0.002578708,0.001531509,0.6356329],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02402626,"threshold_uncertainty_score":0.1270645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02645662342934067,"score_gpt":0.2739332351796624,"score_spread":0.2474766117503217,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}